For fine telangiectasias and spider nevi, CO₂ laser treatment should use the smallest practical spot, low power, and a conservative visual endpoint. A typical approach is continuous-wave or foot-switch–controlled delivery with an approximately 0.2–0.5 mm spot and power in the low single-watt range, targeting individual vessel segments rather than broadly ablating the lesion. Treatment should stop when a minute white coagulated point appears along the vessel; carbonization, charring, and visible tissue vaporization indicate excessive energy.
CO₂ laser is a non-selective thermal tool, not a vessel-specific laser. It can treat isolated superficial lesions when used with meticulous magnification and manual control, but dedicated vascular lasers are generally more forgiving and often preferable for broader or numerous telangiectasias.
Recommended CO₂ Laser Application Protocol
Select a highly localized treatment strategy
Use CO₂ laser primarily for small, isolated telangiectasias, spider nevi, or similar superficial vascular lesions. Treat the visible vessel or central feeding vessel in discrete points rather than scanning or passing repeatedly over the surrounding skin.
A small spot—typically 0.2–0.5 mm—provides the precision needed for individual capillary lines. Some pinhole protocols use approximately 1 mm at about 1 W, with treatment points spaced roughly 3 mm apart; this is a different, more conservative punctate approach and should not be combined automatically with the smaller-spot protocol.
Use low power and controlled delivery
Begin with low power in the range of a few watts or less, depending on the device, handpiece, beam profile, and tissue response. Use continuous or foot-switch–controlled pulsed delivery only when the operator can place each exposure deliberately.
A guiding or aiming beam should be used to confirm spot placement before firing. The foot switch should remain under the operator’s direct control to minimize unintended discharge.
Treat the central feeder when present
For spider nevi, identify the central feeding arteriole and treat it conservatively before addressing selected peripheral branches. Treatment of the feeder may reduce flow through the branching capillary network and can limit unnecessary irradiation of surrounding skin.
For linear telangiectasias, apply brief, precisely placed exposures along the vessel trace rather than creating a continuous ablated line.
Use magnification and reassess continuously
Because CO₂ energy is absorbed broadly by tissue water, the operator should work under visual magnification, such as loupes or an operating microscope when appropriate. Reassess after each exposure instead of delivering a predetermined number of passes.
The absence of tactile feedback is important: unlike a scalpel, the laser does not tell the operator how deep the tissue effect has progressed.
Recognizing the Correct Clinical Endpoint
Stop at a minute white coagulated point
The intended endpoint is a small white coagulated spot directly along the vessel. This represents localized thermal coagulation without unnecessary tissue removal.
The endpoint should remain focal and limited to the target vessel. Progressive whitening, spreading erythema, depression, or tissue desiccation suggests that additional exposure may increase injury without improving vascular clearance.
Avoid carbonization and vaporization
Blackening, charring, smoke from tissue vaporization, or crater formation is not an acceptable endpoint for these superficial vascular lesions. These findings indicate excessive thermal injury and increase the risk of delayed healing and permanent scarring.
Do not continue treatment merely because the entire vessel is not immediately invisible. A conservative first session is safer than attempting aggressive immediate clearance.
Document the response
Record the device, wavelength, spot size, power, mode, exposure pattern, and observed endpoint. Photographing the lesion before and after treatment helps distinguish expected clearance from recurrence or post-inflammatory pigmentary change.
Safety Precautions That Are Mandatory
Protect everyone’s eyes
A medical CO₂ laser emits infrared light at approximately 10,600 nm. Everyone in the treatment area—including the operator, assistants, and observers—must use wavelength-appropriate laser safety eyewear.
The patient’s eyes require protection with suitable opaque photoprotective shields; wet or moist gauze may be used as an additional measure where clinically appropriate, but it should not replace proper eye protection.
Control the laser plume
Laser treatment can generate plume containing irritating or potentially hazardous contaminants. Use an effective local smoke or plume evacuator positioned close to the treatment site.
Do not rely solely on general room ventilation or a surgical mask for plume control.
Prevent ignition
CO₂ laser energy can ignite dry or flammable materials. Use flame-resistant drapes, keep combustible materials away from the beam path, and avoid oxygen-enriched conditions near the treatment field where possible.
Have an appropriate fire-response plan and equipment immediately available.
Control accidental beam delivery
Restrict room access, place appropriate warning signage, and ensure that the device is in a safe or standby state whenever it is not actively being used. The operator should control activation through the foot switch or other deliberate triggering mechanism.
The aiming beam should be visible and correctly aligned before treatment begins.
Patient and Lesion Assessment
Confirm that the lesion is appropriate for treatment
Not every red or vascular-appearing lesion is a benign telangiectasia or spider nevus. Lesions that are atypical, changing, ulcerated, bleeding without clear cause, indurated, or diagnostically uncertain should be evaluated before laser treatment.
CO₂ treatment can alter tissue and potentially complicate later clinical assessment or histopathologic diagnosis.
Consider skin type and pigmentary risk
Patients with a greater tendency toward post-inflammatory hyperpigmentation may require more conservative parameters, careful sun protection, and realistic counseling about pigmentary changes.
The supplementary protocol identifies post-inflammatory hyperpigmentation and local vessel recurrence as possible adverse outcomes.
Establish informed expectations
A treated vessel may not disappear completely during the procedure, and recurrence can occur. Several conservative sessions may be safer than a single aggressive exposure, particularly when the lesion is extensive or the vessel depth is uncertain.
Understanding the Trade-offs
CO₂ laser is less vessel-selective
Vascular lasers target blood chromophores more selectively, whereas CO₂ energy is absorbed by water in both the vessel and surrounding tissue. This makes CO₂ treatment highly dependent on spot placement, exposure duration, and operator control.
For broader facial telangiectasia or multiple lesions, dedicated vascular systems—such as pulsed-dye or long-pulsed Nd:YAG devices when clinically appropriate—are often better suited.
Scarring risk is the central limitation
Because the thermal effect is non-selective, a small deviation in depth or energy can cause unnecessary dermal injury. Permanent scarring is a substantially greater concern when CO₂ treatment is overly aggressive.
Do not use parameters intended for deeper ablation or treatment of epidermal nevi as a template for superficial vascular lesions. The goals, tissue targets, and acceptable endpoints are different.
Immediate visual clearance can be misleading
A vessel that appears to disappear may later reperfuse or recur. Conversely, pursuing complete immediate disappearance can produce excessive thermal damage.
The safest endpoint is controlled focal coagulation, not maximal visible ablation.
Common Pitfalls to Avoid
Using an unnecessarily large spot
Large spots increase collateral heating and reduce precision around fine vessels. Use the smallest spot that reliably covers the target, while recognizing that device-specific beam characteristics may require adjustment.
Treating by power alone
Power settings cannot be interpreted independently of exposure time, spot diameter, mode, handpiece, and tissue response. The operator must evaluate the actual clinical endpoint after each exposure.
Repeating passes over a whitened area
Repeated treatment over an already coagulated point can convert a controlled injury into unnecessary ablation. Pause, reassess under magnification, and avoid cumulative thermal loading.
Ignoring plume, fire, or eye hazards
These are not secondary considerations. Eye protection, plume evacuation, fire prevention, and controlled beam delivery are mandatory components of the procedure.
Applying This Safely in Clinical Practice
CO₂ treatment should be performed only by appropriately trained clinicians using the specific device’s validated instructions and local laser-safety protocols.
- If your primary focus is precision: Use a very small spot, low power, deliberate point-by-point delivery, and magnification, stopping at a minute white coagulated endpoint.
- If your primary focus is minimizing scarring: Avoid carbonization, vaporization, repeated passes, and aggressive attempts at immediate complete clearance.
- If your primary focus is treating multiple or diffuse lesions: Consider a dedicated vascular laser rather than adapting CO₂ to a broader treatment field.
- If your primary focus is procedural safety: Use 10,600-nm eye protection, patient eye shields, plume evacuation, flame-resistant drapes, controlled beam activation, and a restricted treatment area.
- If your primary focus is diagnostic certainty: Confirm that the lesion is clinically appropriate for laser treatment before altering it.
Safe CO₂ treatment of fine telangiectasias and spider nevi depends less on high energy than on precise targeting, continuous visual feedback, and strict avoidance of unnecessary thermal injury.
Summary Table:
| Aspect | Recommendation |
|---|---|
| Spot size | 0.2–0.5 mm (or ~1 mm for pinhole) |
| Power | Low single-watt range (≤ a few watts) |
| Endpoint | Minute white coagulated point; avoid carbonization |
| Treatment technique | Point-by-point, target central feeder for spider nevi |
| Eye protection | Wavelength-specific (10,600 nm) for all; patient shields |
| Plume control | Local smoke evacuator required |
| Fire prevention | Flame-resistant drapes; avoid oxygen-enriched areas |
| Lesion selection | Small, isolated, superficial vascular lesions |
| Skin type consideration | Conservative parameters for higher pigmentary risk |
| Post-op expectations | Possible recurrence; multiple sessions preferred over aggressive ablation |
At BELIS, we provide advanced CO2 fractional, Erbium, and other laser systems designed for precision and safety in aesthetic medicine. Our devices are trusted by clinics and premium salons worldwide, offering reliable performance and comprehensive support. For expert guidance on selecting the ideal laser for your practice, and to leverage our cutting-edge technology to enhance your results, contact us today via our form for a personalized consultation!
Related Products
- Fractional CO2 Laser Machine for Skin Treatment
- Fractional CO2 Laser Machine for Skin Treatment
- Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine
- Cryolipolysis Fat Freezing Machine Cavitation Lipo Laser Machine
- Multifunctional Laser Hair Growth Machine Device for Hair Growth
People Also Ask
- What is the technical principle behind CO2 Laser Fractional micro-perforations? Master Scar Revision Mechanics
- What parameters and treatment intervals are advised when applying fractional CO2 laser technology to delicate periorbital skin laxity? Discover safe protocols for eyelid rejuvenation.
- How do energy-based modalities complement injectable neurotoxins in décolleté rejuvenation? Explore synergistic benefits.
- What is the primary function of a high-precision fractional CO2 laser system for GSM? Restore Vaginal Health Naturally
- Why do fractional CO2 laser parameters need to be differentiated? Master Keloid vs. Hypertrophic Scar Treatment
